BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30858288)

  • 1. Extended Experience in the Use of Antibiotic Lock for Eradication of Biofilm Bacteria on Tenckhoff Catheter.
    Wong SS; Lau WY; Chan PK; Wan CK; Cheng YL
    Perit Dial Int; 2019; 39(2):187-190. PubMed ID: 30858288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Lock in Tenckhoff Catheter for Biofilm-Associated Peritonitis.
    Wong SS; Lau WY; Chan PK; Wan CK; Cheng YL
    Perit Dial Int; 2017; 37(4):475-477. PubMed ID: 28676513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience.
    Sosa Barrios RH; Álvarez Nadal M; Burguera Vion V; Campillo Trapero C; López Melero E; Fernández Lucas M; Rivera Gorrín ME
    J Vasc Access; 2021 Mar; 22(2):261-265. PubMed ID: 32605474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
    Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
    Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal antibiotic administration for prevention of postoperative peritoneal catheter-related infections.
    Kunin M; Dinour D; Rosin D
    Clin Exp Nephrol; 2018 Apr; 22(2):448-452. PubMed ID: 28913721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.
    Chauhan A; Lebeaux D; Ghigo JM; Beloin C
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6310-8. PubMed ID: 23027191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal urokinase and oral rifampicin for persisting asymptomatic dialysate infection following acute coagulase-negative staphylococcus peritonitis.
    Demoulin N; Goffin E
    Perit Dial Int; 2009; 29(5):548-53. PubMed ID: 19776049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro efficacies of various antipseudomonal antibiotics based catheter lock solutions on eradication of Pseudomonas aeruginosa biofilms.
    Ozbek B; Mataraci-Kara E
    J Chemother; 2016; 28(1):20-4. PubMed ID: 25257204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal Dialysis-Related Peritonitis Due to Melioidosis: A Potentially Devastating Condition.
    Kanjanabuch T; Lumlertgul N; Pearson LJ; Chatsuwan T; Pongpirul K; Leelahavanichkul A; Thongbor N; Nuntawong G; Praderm L; Wechagama P; Narenpitak S; Wechpradit A; Punya W; Halue G; Naka P; Jeenapongsa S; Eiam-Ong S
    Perit Dial Int; 2017; 37(2):183-190. PubMed ID: 27738086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.
    Krishnasami Z; Carlton D; Bimbo L; Taylor ME; Balkovetz DF; Barker J; Allon M
    Kidney Int; 2002 Mar; 61(3):1136-42. PubMed ID: 11849468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of exit site care as peritonitis prophylaxis: experience in our centre].
    Conde Rivera O; Santos Nores J; Borrajo Prol M; Pérez Melón C
    Nefrologia; 2010; 30(5):589-91. PubMed ID: 20882098
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis.
    Lopes K; Rocha A; Rodrigues A; Carvalho MJ; Cabrita A
    Int J Artif Organs; 2013 Jul; 36(7):484-8. PubMed ID: 23661559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
    Piątkowska E; Paleczny J; Dydak K; Letachowicz K
    PLoS One; 2021; 16(10):e0258148. PubMed ID: 34618850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).
    Steczko J; Ash SR; Nivens DE; Brewer L; Winger RK
    Nephrol Dial Transplant; 2009 Jun; 24(6):1937-45. PubMed ID: 19181762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for intervention in and prevention of biofilm-related infection in peritoneal dialysis patients.
    Dasgupta MK
    Adv Perit Dial; 2003; 19():195-7. PubMed ID: 14763061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of Screening Peritoneal Dialysis Patients for Bacterial Colonization or Contamination.
    Parthasarathy R; Kashem T; NicFhogartaigh C; Melzer M; Fan SL
    Perit Dial Int; 2019; 39(2):126-133. PubMed ID: 30739095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication of Microorganisms Embedding in Biofilm by a Dose-Dependent Urokinase-Based Catheter Lock Solution in Chronic Hemodialysis Patients.
    Wang J; Peng X; Yin W; Peng Y; Liu H; He L
    Blood Purif; 2020; 49(5):586-596. PubMed ID: 31935721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Lock Therapy in the Era of Gram-Negative Resistance.
    Soman R; Gupta N; Suthar M; Kothari J; Almeida A; Shetty A; Rodrigues C
    J Assoc Physicians India; 2016 Feb; 64(2):32-37. PubMed ID: 27730778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.